Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol fMRI response in knee osteoarthritis
NCT01105936Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Paracetamol with Placebo (2 arms). Primary endpoint: Blood Oxygen Level-Dependent Response in the Tibio-femoral Joint. Started Sep 2010; status: completed.
02
Drugs
acetaminophen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01105936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105936.